New York Ventures

New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the Regional Economic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.

Audrey Chisholm

Investment Associate

Silvia Garcia Codony

Assistant Vice President

Hope Knight

President, CEO and Commissioner

Heidi Knoblauch

Senior Director

Josh Nelson

Director

Ryoko Nozawa

Senior Director

Past deals in New York

ZetaGen Therapeutics

Series B in 2023
ZetaGen Therapeutics Inc is a preclinical regenerative medicine company focused on developing innovative products for bone regeneration. Founded in 2015 and based in Syracuse, New York, the company utilizes a small molecule-based osteoinductive platform that targets a novel molecular pathway to create solutions for bone-related injuries, procedures, and diseases. ZetaGen's technology aims to halt cancer progression, alleviate pain, and promote bone healing, thereby improving treatment outcomes for patients and healthcare providers alike. By combining drug and device elements, the company aspires to transform the landscape of bone regeneration therapies.

Envisagenics

Series A in 2023
Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.

C16 Biosciences

Series A in 2023
C16 Biosciences, Inc. is a biotechnology company based in New York, established in 2017, specializing in the production of sustainable alternatives to palm oil through microbiology and fermentation processes. The firm focuses on creating innovative ingredients for food manufacturers, refiners, and consumers, aiming to decarbonize the supply chains of consumer product brands. C16 Biosciences has developed the Palmless™ platform, which features its first biodesigned ingredient, Torula oil—a premium bioactive oil known for its clinically proven benefits for skin and hair health. By leveraging biomanufacturing techniques, the company provides scalable and sustainable options, addressing the demand for environmentally friendly alternatives in the oil and fat market.

Ursa Space Systems

Series B in 2023
Ursa Space Systems Inc. is a geospatial services company that provides aerial and space-based data products to enhance geographic mapping and location-based information. Its offerings include imagery and information products that support market and weather forecasting, agricultural yield improvement, disaster response, and military intelligence. The company is known for its Ursa Global Oil Storage Monitoring solution, which provides insights into global oil storage for hedge funds, commodities traders, banks, and oil companies. Ursa Space Systems serves various sectors, including precision agriculture, business intelligence, weather monitoring, humanitarian relief, civil protection, mapping, and traffic applications. Founded in 2014, the company is headquartered in Ithaca, New York, and leverages radar satellite data to deliver timely reports, fostering transparency in global markets for the finance and energy industries.

BlocPower

Series B in 2023
BlocPower is an energy technology startup based in Los Angeles, California, focused on creating healthier, greener, and smarter buildings. Founded in 2014 in Brooklyn, New York, by Donnel Baird and Morris Cox, the company specializes in retrofitting urban buildings with advanced energy efficiency technologies and green heating and cooling systems. BlocPower identifies energy-wasting buildings and utilizes a proprietary machine learning platform to determine the most effective retrofits for maximizing energy savings. The company connects various stakeholders, including government agencies, utilities, building owners, and equipment providers, to facilitate these upgrades. With a mission to serve financially underserved communities, BlocPower has completed projects in nearly 1,000 buildings, helping customers save 20–40% on their annual energy bills. By leveraging data and innovative financing, BlocPower aims to reduce carbon emissions and improve health outcomes while addressing the climate crisis.

Juno Medical

Series A in 2022
Juno Care is a whole-family healthcare platform that provides modern open-access care for the entire family’s day-to-day needs, including pediatrics, women’s health, adult primary care, and same-day services. The company was founded in 2020 and is based in New York, New York, United States.

ZetaGen Therapeutics

Series B in 2022
ZetaGen Therapeutics Inc is a preclinical regenerative medicine company focused on developing innovative products for bone regeneration. Founded in 2015 and based in Syracuse, New York, the company utilizes a small molecule-based osteoinductive platform that targets a novel molecular pathway to create solutions for bone-related injuries, procedures, and diseases. ZetaGen's technology aims to halt cancer progression, alleviate pain, and promote bone healing, thereby improving treatment outcomes for patients and healthcare providers alike. By combining drug and device elements, the company aspires to transform the landscape of bone regeneration therapies.

Qunnect

Series A in 2022
Qunnect, LLC specializes in developing modular light-based devices that facilitate the transmission, storage, and reception of encrypted information, aimed at creating large-area ultra-secure networks. Utilizing principles of quantum physics, these devices ensure that any attempt to observe the data alerts both the sender and recipient, thereby enhancing cybersecurity. Founded in 2017 and based in Stony Brook, New York, Qunnect emerged as a spin-off from the Quantum Information Technology group at Stony Brook University. The company's focus is on engineering advanced quantum memories and sources, which are crucial for future information networks and quantum computing. Additionally, Qunnect offers field-deployable hardware systems for optical and long-distance communication, along with an AI-enabled software suite that allows for real-time monitoring of network components. This innovative approach positions Qunnect at the forefront of evolving cyber-security markets by enabling sophisticated and scalable quantum-secure communication solutions.

GDI

Series A in 2022
GDI develops and manufactures silicon anodes for Li-ion batteries. The company was founded in 2009 and is based in Rochester, New York.

Ellevest

Series B in 2022
Ellevest, Inc. is an investment management firm founded in 2014 and based in New York City, focusing primarily on providing financial services to women. The firm manages customized client portfolios across various asset classes globally, employing fundamental analysis and a top-down approach in its investment strategy. Ellevest has developed a digital investment platform that offers a personalized experience, utilizing proprietary algorithms tailored to women's financial needs, including salary peaks and goal-specific portfolios. This platform aims to empower female investors by helping them take control of their investments and achieve their financial goals through a user-friendly interface and thoughtful portfolio construction.

The Cru

Seed Round in 2022
The Cru provides a peer coaching service for women looking to accelerate their professional and personal growth. It takes the work out of networking and helps women to achieve their goals. The company was founded in 2018 and is based in New York.

BlocPower

Venture Round in 2022
BlocPower is an energy technology startup based in Los Angeles, California, focused on creating healthier, greener, and smarter buildings. Founded in 2014 in Brooklyn, New York, by Donnel Baird and Morris Cox, the company specializes in retrofitting urban buildings with advanced energy efficiency technologies and green heating and cooling systems. BlocPower identifies energy-wasting buildings and utilizes a proprietary machine learning platform to determine the most effective retrofits for maximizing energy savings. The company connects various stakeholders, including government agencies, utilities, building owners, and equipment providers, to facilitate these upgrades. With a mission to serve financially underserved communities, BlocPower has completed projects in nearly 1,000 buildings, helping customers save 20–40% on their annual energy bills. By leveraging data and innovative financing, BlocPower aims to reduce carbon emissions and improve health outcomes while addressing the climate crisis.

Wesper

Seed Round in 2021
Wesper, formerly known as Tatch Inc., is a company that specializes in the development of a wireless sleep diagnostic patch designed to enhance sleep medicine. Incorporated in 2017 and based in New York, the company utilizes advanced flexible electronics, machine learning, and wearable technology to provide comprehensive sleep analysis in a comfortable setting. The patch monitors various physiological parameters, including respiratory effort, oxygen levels, heart rate, body position, movement, and snoring. This technology allows for the diagnosis of sleep disorders such as sleep apnea, restless leg syndrome, and insomnia, enabling both patients and healthcare providers to gain valuable insights into sleep quality and health.

Envisagenics

Series A in 2021
Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.

REDIST

Seed Round in 2021
A platform making it easy for real estate professionals to find and use the more than $100b in annual real estate incentives; saving time and money on deals. Our current geographic coverage is New York, New Jersey, Connecticut, Massachusetts, Pennsylvania, Florida, Washington D.C. and Virginia. We are located at the Columbia Startup Lab, are currently in Lowenstein Sandler's VentureCrush FG as well as Shadow Ventures Incubator and have recently completed Accelerate 2020 with Bowery Capital and Silicon Valley Bank.

Ursa Space Systems

Series B in 2021
Ursa Space Systems Inc. is a geospatial services company that provides aerial and space-based data products to enhance geographic mapping and location-based information. Its offerings include imagery and information products that support market and weather forecasting, agricultural yield improvement, disaster response, and military intelligence. The company is known for its Ursa Global Oil Storage Monitoring solution, which provides insights into global oil storage for hedge funds, commodities traders, banks, and oil companies. Ursa Space Systems serves various sectors, including precision agriculture, business intelligence, weather monitoring, humanitarian relief, civil protection, mapping, and traffic applications. Founded in 2014, the company is headquartered in Ithaca, New York, and leverages radar satellite data to deliver timely reports, fostering transparency in global markets for the finance and energy industries.

Cureatr

Series B in 2021
Cureatr Inc. is a New York-based company that provides mobile care coordination solutions for healthcare providers. Established in 2011, it combines HIPAA-secure text messaging with workflow navigation tools to enhance communication and coordination among healthcare professionals. The company has developed a cloud-based medication management software that focuses on optimizing patient care, particularly in post-discharge settings. This software facilitates medication reconciliation and other medical services triggered by real-time events following a patient's discharge from acute care. Additionally, it features a dashboard that organizes and analyzes patients' medication histories, enabling healthcare professionals to improve their coordination with patients effectively.

Energy Materials Corporation

Series A in 2021
Energy Materials Corporation develops high-speed, roll-to-roll printing of purebred perovskite solar panels. The company was founded in 2010 and based in Rochester, New York.

Mosaic Microsystems

Seed Round in 2021
Mosaic Microsystems LLC is a microelectronics and photonics packaging company based in Rochester, New York. Founded in 2016, the company specializes in using glass and other thin substrates as a platform material for a variety of applications, including logic, memory, analog and power electronics, photonics, RF, MEMS, and sensor technologies. Mosaic Microsystems aims to enable manufacturers to achieve high-volume production of thin glass components, providing innovative packaging solutions that integrate seamlessly into diverse microelectronics applications.

ENB Therapeutics

Series A in 2021
ENB Therapeutics is a biopharmaceutical company focused on developing small molecule inhibitors aimed at treating melanoma and other cancers. Founded in 2015 and headquartered in New York, the company’s lead product, ENB-001, is a selective endothelin B receptor (ETBR) inhibitor. This innovative therapy has shown promise in preclinical studies to reduce tumor growth and enhance survival rates in cancer models by restoring T-cell infiltration into tumors and inhibiting metastasis. ENB-001 has received Orphan Drug Designation from the FDA, ensuring market exclusivity and strong intellectual property protection. The company is also developing a companion diagnostic to identify patients with over-expressed ETBR pathways, which may allow for expansion into multiple tumor types. By addressing drug resistance commonly seen in cancer patients, ENB Therapeutics aims to establish new standards of care that enhance the effectiveness of existing immunotherapy treatments and improve patient outcomes.

BlocPower

Series A in 2021
BlocPower is an energy technology startup based in Los Angeles, California, focused on creating healthier, greener, and smarter buildings. Founded in 2014 in Brooklyn, New York, by Donnel Baird and Morris Cox, the company specializes in retrofitting urban buildings with advanced energy efficiency technologies and green heating and cooling systems. BlocPower identifies energy-wasting buildings and utilizes a proprietary machine learning platform to determine the most effective retrofits for maximizing energy savings. The company connects various stakeholders, including government agencies, utilities, building owners, and equipment providers, to facilitate these upgrades. With a mission to serve financially underserved communities, BlocPower has completed projects in nearly 1,000 buildings, helping customers save 20–40% on their annual energy bills. By leveraging data and innovative financing, BlocPower aims to reduce carbon emissions and improve health outcomes while addressing the climate crisis.

Mymee

Venture Round in 2021
Mymee, Inc. is a New York-based company that offers a software as a service health coaching platform specifically designed for individuals suffering from incurable rheumatic and neurological autoimmune diseases. Founded in 2011, Mymee focuses on identifying the unique dietary and environmental triggers that may exacerbate symptoms for each user. The platform utilizes personalized data gathering and analysis to develop tailored care plans, supported by certified health coaches who guide users in making necessary behavioral changes. Mymee's approach has shown clinically significant improvements in health-related quality of life for many participants, addressing issues such as fatigue and pain. By empowering individuals to take control of their health through targeted interventions, Mymee aims to reduce disease flares and enhance overall well-being.

Free Form Fibers

Seed Round in 2020
Free Form Fibers LLC specializes in the development and manufacture of inorganic high-performance fibers using advanced laser-driven chemical vapor deposition technology. The company produces a wide range of filament materials, including silicon carbide, boron carbide, tungsten carbide, and diamond-like carbon, among others. These fibers are designed for various applications such as non-woven filters, catalysts, reinforcement in ceramic and metal matrix composites, and superconducting filaments. Free Form Fibers serves diverse industries, including military and aerospace, automotive, biomedical, and energy, providing solutions that require heat and chemical resistance. Established in 2006 and based in Saratoga Springs, New York, the company focuses on delivering low-cost, high-performance materials for demanding applications.

Artemis

Series A in 2020
Artemis develops a cultivation management platform designed for enterprise greenhouses, indoor farms, and high tunnel farms. This software enables growers to efficiently manage people, plants, processes, and compliance by providing a comprehensive view of facility productivity. Users can track operations and production data remotely through desktops, tablets, or smartphones. The platform allows owners and managers to oversee workflows, register crop batches, address food safety issues, manage personnel, and gain insights to enhance crop productivity. Founded in 2015 and originally named Agrilyst, the company rebranded to Artemis in May 2019 and is headquartered in Brooklyn, New York.

Envisagenics

Series A in 2020
Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.

The Cru

Seed Round in 2020
The Cru provides a peer coaching service for women looking to accelerate their professional and personal growth. It takes the work out of networking and helps women to achieve their goals. The company was founded in 2018 and is based in New York.

Urban Electric Power

Series B in 2020
Urban Electric Power LLC, founded in 2012 and based in Pearl River, New York, specializes in developing rechargeable zinc anode electricity storage technology. The company offers innovative products such as nickel-zinc (Ni-Zn) flow-assisted battery systems and affordable rechargeable zinc-manganese dioxide (MnO2-Zn) batteries. By transforming traditional alkaline batteries into powerful rechargeable alternatives, Urban Electric Power addresses the shortcomings of existing battery solutions in modern energy infrastructure. The company’s technology leverages earth-abundant materials sourced from allied nations, promoting safe and sustainable supply chains. Urban Electric Power aims to enhance electricity access and reliability, particularly in developing regions where lead-acid batteries are commonly used, thus supporting public health, education, and economic growth through cleaner, renewable energy solutions.

Redpin Therapeutics

Series A in 2020
Redpin Therapeutics is a preclinical stage gene therapy company based in New York, founded in 2017. The company specializes in developing a proprietary chemogenetics platform designed to create targeted cell therapies for intractable diseases of the nervous system. Its innovative approach combines principles from synthetic biology, gene therapy, and conventional pharmacotherapy, utilizing ion channels as neuromodulation tools. This enables selective activation or inhibition of disease-causing neurons, allowing for precise regulation of dysfunctional neuronal circuits while sparing healthy cells. Through its research and development efforts, Redpin Therapeutics aims to provide new treatment options for challenging neurological conditions.

GiveGab

Series A in 2020
GiveGab provides services for fundraising professionals to raise money online. Designed for cause-based organizations, community foundations, and education institutions, GiveGab offers a complete suite of products and services. The company was founded in 2011 and headquartered in Ithaca, New York.

Kinvolved

Seed Round in 2020
Kinvolved, Inc. is a technology company that specializes in mobile and web applications aimed at enhancing communication between schools and families. Its flagship product, KiNVO, facilitates communication regarding attendance, behavior, grades, and other important updates, allowing schools to send messages to entire classrooms or individual parents. The platform also provides valuable data analytics, enabling educators to track attendance and communication trends, flag chronically absent students, and generate reports on student-specific interactions with parents. Kinvolved's solutions target schools and after-school programs, particularly in underserved communities across the United States, with the goal of improving student attendance and reducing chronic absenteeism. Founded in 2012 and based in New York City, Kinvolved combines technology with community engagement to foster better educational outcomes and enhance graduation rates.

Ride Health

Series A in 2020
Ride Health LLC is a New York-based company that offers a software-as-a-service platform designed to improve patient access to medical appointments by managing transportation logistics. Founded in 2016, the platform enables healthcare providers to schedule, request, and pay for rides on behalf of patients, addressing transportation barriers that can hinder access to care. It allows coordinators to arrange rides in advance or on-demand, provides real-time updates and reminders to patients, and offers insights into transportation costs and usage. By partnering with healthcare organizations and transportation providers, Ride Health enhances enterprise transportation programs and supports at-risk populations, ensuring that patient needs and preferences are prioritized. This approach aims to improve efficiencies, reduce costs, and ultimately foster better healthcare outcomes.

Soundmind

Seed Round in 2019
Soundmind Intelligence, Inc. is a company based in Brooklyn, New York, that provides a platform featuring conversational A.I. voice assistants specifically designed for senior care providers. Founded in 2018, the company's technology aims to reduce social isolation among older adults by enhancing communication and connectivity. Its voice assistants enable caregivers and administrators to manage accounts for elder residents, offering personalized features such as care plans, calendars, reminders, messaging, and entertainment. By streamlining these functions through voice interaction, Soundmind facilitates improved communication between caregivers, residents, and their families, ultimately supporting better care in senior living environments.

GDI

Series A in 2019
GDI develops and manufactures silicon anodes for Li-ion batteries. The company was founded in 2009 and is based in Rochester, New York.

Ursa Space Systems

Series B in 2019
Ursa Space Systems Inc. is a geospatial services company that provides aerial and space-based data products to enhance geographic mapping and location-based information. Its offerings include imagery and information products that support market and weather forecasting, agricultural yield improvement, disaster response, and military intelligence. The company is known for its Ursa Global Oil Storage Monitoring solution, which provides insights into global oil storage for hedge funds, commodities traders, banks, and oil companies. Ursa Space Systems serves various sectors, including precision agriculture, business intelligence, weather monitoring, humanitarian relief, civil protection, mapping, and traffic applications. Founded in 2014, the company is headquartered in Ithaca, New York, and leverages radar satellite data to deliver timely reports, fostering transparency in global markets for the finance and energy industries.

Cureatr

Series B in 2019
Cureatr Inc. is a New York-based company that provides mobile care coordination solutions for healthcare providers. Established in 2011, it combines HIPAA-secure text messaging with workflow navigation tools to enhance communication and coordination among healthcare professionals. The company has developed a cloud-based medication management software that focuses on optimizing patient care, particularly in post-discharge settings. This software facilitates medication reconciliation and other medical services triggered by real-time events following a patient's discharge from acute care. Additionally, it features a dashboard that organizes and analyzes patients' medication histories, enabling healthcare professionals to improve their coordination with patients effectively.

GiveGab

Series A in 2019
GiveGab provides services for fundraising professionals to raise money online. Designed for cause-based organizations, community foundations, and education institutions, GiveGab offers a complete suite of products and services. The company was founded in 2011 and headquartered in Ithaca, New York.

Urban Electric Power

Series B in 2019
Urban Electric Power LLC, founded in 2012 and based in Pearl River, New York, specializes in developing rechargeable zinc anode electricity storage technology. The company offers innovative products such as nickel-zinc (Ni-Zn) flow-assisted battery systems and affordable rechargeable zinc-manganese dioxide (MnO2-Zn) batteries. By transforming traditional alkaline batteries into powerful rechargeable alternatives, Urban Electric Power addresses the shortcomings of existing battery solutions in modern energy infrastructure. The company’s technology leverages earth-abundant materials sourced from allied nations, promoting safe and sustainable supply chains. Urban Electric Power aims to enhance electricity access and reliability, particularly in developing regions where lead-acid batteries are commonly used, thus supporting public health, education, and economic growth through cleaner, renewable energy solutions.

Concertio

Seed Round in 2019
Concertio is a premier provider of AI-powered performance optimization tools for the hardware and software markets. It also provides AI-powered performance optimization tools that boost the performance of computing systems by tailoring the many system settings in processors, firmware, OS and applications to the running workloads. The company tools are used by the likes of Intel, Marvell, and Mellanox to boost the performance of a multitude of devices and applications, turning general-purpose systems into high-performant special-purpose systems. The optimizer studio integrates performance optimization software suite that monitors (and learns from) the interactions between applications and systems, to deliver optimal configuration settings for peak performance. Concertio was founded in 2016 and is headquartered in New York, NY, USA.

Vyv

Seed Round in 2019
Vyv, formerly known as Vital Vio, Inc., specializes in the design and manufacture of antimicrobial lighting systems under the VioSafe brand. The company produces a range of products, including under cabinet lights, T8 replacement bulbs, and various types of LED luminaires, all engineered to combat infectious pathogens. These innovative lighting solutions are employed in diverse commercial environments such as hospitals, laboratories, food storage facilities, gyms, and schools, among others. Vyv's technology leverages visible light to disrupt the cell membranes of harmful bacteria and viruses, providing a continuous method for infection control. Established in 2012 and based in Troy, New York, the company serves a broad clientele, including notable institutions like Duke University and UCLA Health, and also explores licensing opportunities for consumer and residential applications.

Unite Us

Series B in 2019
Unite Us is a veteran-led technology company that specializes in creating coordinated care networks that connect health and social service providers. Founded in 2013 by veterans Dan Brillman and Taylor Justice in New York, the company focuses on integrating social determinants of health into patient care to enhance the delivery of services. Its platform enables providers to securely send and receive referrals, track each individual's health journey, and report on outcomes across various services. By fostering a centralized and collaborative ecosystem, Unite Us empowers communities to move beyond traditional resource directories, allowing them to effectively measure impact and improve health outcomes at scale.

Loliware

Seed Round in 2019
Loliware LLC is a company based in Beacon, New York, that specializes in manufacturing biodegradable and edible disposable cups and other single-use products aimed at eliminating plastic waste. Founded in 2015, the company has developed an innovative range of products made from bio-renewable seaweed, which are designed to be compostable and environmentally friendly. Loliware's mission is to promote a plastic-free, decarbonized future by offering alternatives that are not only compostable but also have a lower carbon footprint compared to traditional plastics. Their initial product, an ocean-safe and tree-free drinking straw, has received accolades for its potential to set new industry standards. The company is actively working on expanding its product line, with plans to introduce six new items by the end of 2023, all of which aim to provide sustainable solutions for chefs, restaurant chains, and eco-conscious businesses looking to reduce their environmental impact.

GiveGab

Series A in 2018
GiveGab provides services for fundraising professionals to raise money online. Designed for cause-based organizations, community foundations, and education institutions, GiveGab offers a complete suite of products and services. The company was founded in 2011 and headquartered in Ithaca, New York.

Cureatr

Series B in 2018
Cureatr Inc. is a New York-based company that provides mobile care coordination solutions for healthcare providers. Established in 2011, it combines HIPAA-secure text messaging with workflow navigation tools to enhance communication and coordination among healthcare professionals. The company has developed a cloud-based medication management software that focuses on optimizing patient care, particularly in post-discharge settings. This software facilitates medication reconciliation and other medical services triggered by real-time events following a patient's discharge from acute care. Additionally, it features a dashboard that organizes and analyzes patients' medication histories, enabling healthcare professionals to improve their coordination with patients effectively.

Artemis

Venture Round in 2018
Artemis develops a cultivation management platform designed for enterprise greenhouses, indoor farms, and high tunnel farms. This software enables growers to efficiently manage people, plants, processes, and compliance by providing a comprehensive view of facility productivity. Users can track operations and production data remotely through desktops, tablets, or smartphones. The platform allows owners and managers to oversee workflows, register crop batches, address food safety issues, manage personnel, and gain insights to enhance crop productivity. Founded in 2015 and originally named Agrilyst, the company rebranded to Artemis in May 2019 and is headquartered in Brooklyn, New York.

Cureatr

Venture Round in 2018
Cureatr Inc. is a New York-based company that provides mobile care coordination solutions for healthcare providers. Established in 2011, it combines HIPAA-secure text messaging with workflow navigation tools to enhance communication and coordination among healthcare professionals. The company has developed a cloud-based medication management software that focuses on optimizing patient care, particularly in post-discharge settings. This software facilitates medication reconciliation and other medical services triggered by real-time events following a patient's discharge from acute care. Additionally, it features a dashboard that organizes and analyzes patients' medication histories, enabling healthcare professionals to improve their coordination with patients effectively.

Loliware

Seed Round in 2018
Loliware LLC is a company based in Beacon, New York, that specializes in manufacturing biodegradable and edible disposable cups and other single-use products aimed at eliminating plastic waste. Founded in 2015, the company has developed an innovative range of products made from bio-renewable seaweed, which are designed to be compostable and environmentally friendly. Loliware's mission is to promote a plastic-free, decarbonized future by offering alternatives that are not only compostable but also have a lower carbon footprint compared to traditional plastics. Their initial product, an ocean-safe and tree-free drinking straw, has received accolades for its potential to set new industry standards. The company is actively working on expanding its product line, with plans to introduce six new items by the end of 2023, all of which aim to provide sustainable solutions for chefs, restaurant chains, and eco-conscious businesses looking to reduce their environmental impact.

GDI

Seed Round in 2018
GDI develops and manufactures silicon anodes for Li-ion batteries. The company was founded in 2009 and is based in Rochester, New York.

GiveGab

Series A in 2018
GiveGab provides services for fundraising professionals to raise money online. Designed for cause-based organizations, community foundations, and education institutions, GiveGab offers a complete suite of products and services. The company was founded in 2011 and headquartered in Ithaca, New York.

Redpin Therapeutics

Venture Round in 2018
Redpin Therapeutics is a preclinical stage gene therapy company based in New York, founded in 2017. The company specializes in developing a proprietary chemogenetics platform designed to create targeted cell therapies for intractable diseases of the nervous system. Its innovative approach combines principles from synthetic biology, gene therapy, and conventional pharmacotherapy, utilizing ion channels as neuromodulation tools. This enables selective activation or inhibition of disease-causing neurons, allowing for precise regulation of dysfunctional neuronal circuits while sparing healthy cells. Through its research and development efforts, Redpin Therapeutics aims to provide new treatment options for challenging neurological conditions.

Quentis Therapeutics

Series A in 2018
Quentis Therapeutics, Inc. is a biotechnology company based in New York, founded in 2016. The company specializes in developing immunotherapies that target endoplasmic reticulum (ER) stress response pathways within the tumor microenvironment. By addressing ER stress, Quentis aims to enhance the immune system's capacity to combat cancer, providing patients with innovative treatment options. Its therapeutic approach focuses on awakening anti-tumor immunity, thereby potentially improving outcomes for individuals facing various forms of cancer.

Forkhead BioTherapeutics

Seed Round in 2018
Forkhead BioTherapeutics Inc is focused on developing innovative oral therapies for insulin-dependent diabetes. Based in New York, the company has created Foxin, an oral agent designed to target and delete the FOXO1 protein, which plays a crucial role in regulating insulin production and glucose metabolism. Founded in 2017, Forkhead Bio aims to harness the natural processes of cell conversion and regeneration to create transformative treatments that enhance the quality of life for patients with diabetes.

Vyv

Venture Round in 2018
Vyv, formerly known as Vital Vio, Inc., specializes in the design and manufacture of antimicrobial lighting systems under the VioSafe brand. The company produces a range of products, including under cabinet lights, T8 replacement bulbs, and various types of LED luminaires, all engineered to combat infectious pathogens. These innovative lighting solutions are employed in diverse commercial environments such as hospitals, laboratories, food storage facilities, gyms, and schools, among others. Vyv's technology leverages visible light to disrupt the cell membranes of harmful bacteria and viruses, providing a continuous method for infection control. Established in 2012 and based in Troy, New York, the company serves a broad clientele, including notable institutions like Duke University and UCLA Health, and also explores licensing opportunities for consumer and residential applications.

Unite Us

Series A in 2017
Unite Us is a veteran-led technology company that specializes in creating coordinated care networks that connect health and social service providers. Founded in 2013 by veterans Dan Brillman and Taylor Justice in New York, the company focuses on integrating social determinants of health into patient care to enhance the delivery of services. Its platform enables providers to securely send and receive referrals, track each individual's health journey, and report on outcomes across various services. By fostering a centralized and collaborative ecosystem, Unite Us empowers communities to move beyond traditional resource directories, allowing them to effectively measure impact and improve health outcomes at scale.

PostProcess

Seed Round in 2017
PostProcess Technologies Inc. specializes in automated solutions for post-printing processes in additive manufacturing. Founded in 2014 and headquartered in Buffalo, New York, with an additional location in Sophia-Antipolis, France, the company develops a combination of software, hardware, and chemistry to streamline support removal and surface finishing for 3D printed parts. Its offerings include automated systems for resin removal and surface finishing, such as submersion and spray systems, as well as a range of consumables and hybrid products tailored for various industries, including aerospace, defense, automotive, consumer goods, dental, and medical sectors. By addressing the challenges of post-printing, PostProcess Technologies enhances production efficiency and precision across different 3D printing technologies.

GDI

Seed Round in 2016
GDI develops and manufactures silicon anodes for Li-ion batteries. The company was founded in 2009 and is based in Rochester, New York.

ChannelEyes

Venture Round in 2016
Founded in 2011, ChannelEyes is a global software company that is reinventing how vendors drive channel partner sales and loyalty. The SaaS platform includes ChannelCandy, the world’s largest mobile-first product for partners, as well as OPTYX, the first indirect sales workflow product to help sellers with predictive analytics and leverage big data science to drive more sales. ChannelEyes has received numerous accolades for its technology including being named a Cool Vendor by Gartner and one of the fastest growing companies in New York’s Capital Region by the Business Review. Learn more at: http://channeleyes.com/

Unite Us

Series A in 2015
Unite Us is a veteran-led technology company that specializes in creating coordinated care networks that connect health and social service providers. Founded in 2013 by veterans Dan Brillman and Taylor Justice in New York, the company focuses on integrating social determinants of health into patient care to enhance the delivery of services. Its platform enables providers to securely send and receive referrals, track each individual's health journey, and report on outcomes across various services. By fostering a centralized and collaborative ecosystem, Unite Us empowers communities to move beyond traditional resource directories, allowing them to effectively measure impact and improve health outcomes at scale.

Cureatr

Series B in 2015
Cureatr Inc. is a New York-based company that provides mobile care coordination solutions for healthcare providers. Established in 2011, it combines HIPAA-secure text messaging with workflow navigation tools to enhance communication and coordination among healthcare professionals. The company has developed a cloud-based medication management software that focuses on optimizing patient care, particularly in post-discharge settings. This software facilitates medication reconciliation and other medical services triggered by real-time events following a patient's discharge from acute care. Additionally, it features a dashboard that organizes and analyzes patients' medication histories, enabling healthcare professionals to improve their coordination with patients effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.